JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 ,inter alia, to consider and approve Audited Financial Results for the Quarter and Financial Year ended on 31.03.2024 and to consider recommendation of dividend, if any.